Abstract
SIGNIFICANCE: This analysis and review demonstrate that, although emerging data indicate that the prevalence of severe acute respiratory coronavirus 2 (SARS‐CoV‐2) on the ocular surface and coronavirus disease 2019 (COVID‐19) conjunctivitis is rare, the ocular surface remains of interest as a potential inoculation and transmission site for SARS‐CoV‐2. Continued safety precautions should be taken as more data become available. COVID‐19, caused by SARS‐CoV‐2, is a novel, global pandemic that has infected millions and, up to this point, caused more than two million fatalities worldwide. The ocular surface has become of interest as a possible vector for transmission by acting as a direct inoculation site, being a conduit for the virus into the respiratory system or as a method of transmission from potentially infected conjunctiva or tears. The components necessary for SARS‐CoV‐2 to theoretically infect ocular tissues are present: binding receptors (angiotensin‐converting enzyme 2 and cluster of differentiation 147) and mechanisms for cell entry (transmembrane protease serine 2 and cathepsin L). This meta‐analysis of COVID‐19 prevalence data indicates that SARS‐CoV‐2 RNA has been infrequently found in conjunctival samples when tested with reverse transcriptase–polymerase chain reaction. This review estimates the prevalence of SARS‐CoV‐2 on the ocular surface and prevalence of conjunctivitis in patients with laboratory‐confirmed COVID‐19. There is much to be learned regarding ocular tropism of SARS‐CoV‐2.